scholarly journals Access and equity to cancer care in the USA: a review and assessment

2005 ◽  
Vol 81 (961) ◽  
pp. 674-679 ◽  
Author(s):  
L A Siminoff
2007 ◽  
Vol 4 (11) ◽  
pp. 643-656 ◽  
Author(s):  
K Robin Yabroff ◽  
Joan L Warren ◽  
Martin L Brown
Keyword(s):  

2013 ◽  
Vol 12 (1-2) ◽  
pp. 0-0
Author(s):  
Narimantas Evaldas Samalavičius

Dear colleagues,It is my great privilege and pleasure to welcome you to the international conference “From bench to bed: challenges in cancer care” devoted to a very broad number of topics in oncology. It is of utmost importance to stress that during this event we are celebrating the 80th anniversary of the Lithuanian Society of Oncology – just to stress how deep and long are the traditions of oncology in our country. I am very pleased to note that this event attracted as many as 25 international speakers from Russia, Belarus, Ukraine, Poland, Italy, Belgium, Switzerland, Germany, the United Kingdom, Austria, France, Canada, the USA, Taiwan.It has been quite a tradition that during the last years the Oncology Institute of Vilnius University has been organizing meetings dealing with many specialities and subspecialties in oncology, such as diagnostics, surgery, medical oncology, psychooncology, etc. This time, we decided to cover most of the important issues in this field, thus allowing a very large number of different medical professionals to benefit from this magnificient arrangement.Needless to remind you that in recent years a very big step has been made in oncology worldwide: among a number of aspects, cancer diagnosis has been armed with new modalities we could only dream of several decades ago; minimally invasive surgical techniques, including robotics, became an unseperable part of surgical oncology; radiation therapy crossed the borders we ever though we had, and today’s cancer therapy enables us to approach cancer with different targeted drugs in the light of understanding the newly discovered mechanisms. However, there is so much yet to do: some oncological diseases are still as fatal as they were, modern treatments are a huge bondage to our societies due to dramatically increasing costs, stressing the further need of cancer prevention and early diagnosis.I do hope that this unique place in our tiny Lithuania, called Druskininkai, in the light of the soft autumnal sun will help us to create a truly scientific atmosphere; the meeting itself will be a start for new ideas, new thoughts, and new steps in our research and practice. At the same time, the social program will offer us a true relax and a succesfull return to our daily activites next week.Yours truly –Prof. NARIMANTAS EVALDAS SAMALAVICIUSDirector of the Institute of Oncology, Vilnius University


2019 ◽  
Vol 25 (5) ◽  
pp. 948-952
Author(s):  
Jessica Maxwell ◽  
Oleg Shats ◽  
Joshua Aldridge ◽  
Elizabeth Lyden ◽  
Amy Krie ◽  
...  

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e19213-e19213
Author(s):  
Fidel Rubagumya ◽  
Gunita Mitera ◽  
Sidy Ka ◽  
Achille Van Christ Manirakiza ◽  
Phillipa Kibugu-Decuir ◽  
...  

e19213 Background: Choosing Wisely Africa, builds on Choosing Wisely (CW) in the USA, Canada and India, and aims to identify low-value, unnecessary, or harmful cancer practices that are frequently used on the African continent. Methods: The CWA Task Force was convened by African Organization for Research and Training in Cancer (AORTIC) and included representatives in surgical, medical and radiation oncology, the private and public sectors and patient advocacy group. Consensus was built through a modified Delphi process shortening a long list of practices to a short list then to a final list. Results: Of the 10 practices on the final list, one is a new suggestion, 9 are revisions or adaptations of practices from previous CW campaign lists. One item relates to palliative care, 8 concern treatment, and 1 relates to surveillance. Conclusions: The success of this campaign will be measured by how the list is implemented across sub-Saharan Africa and whether it improves the delivery of high-quality cancer care. [Table: see text]


2021 ◽  
Author(s):  
Amir Alishahi Tabriz ◽  
Kea Turner ◽  
Alecia Clary ◽  
Young-Rock Hong ◽  
Oliver T Nguyen ◽  
...  

Abstract Background Accumulating evidence suggests that interventions to de-implement low-value services are urgently needed. While medical societies and educational campaigns such as Choosing Wisely have developed several guidelines and recommendations pertaining to low-value care, little is known about interventions that exist to de-implement low-value care in oncology settings. We conducted this review to summarize the literature on interventions to de-implement low-value care in oncology settings, define an agenda for future research, and inform the literature about opportunities for additional work. Methods We systematically reviewed the published literature in PubMed, Embase, CINAHL Plus, and Scopus. We screened the retrieved abstracts for eligibility against inclusion criteria and conducted a full-text review of all eligible studies on de-implementation interventions in cancer care delivery. We used the framework analysis approach to summarize included studies' key characteristics including design; outcome(s); type of cancer, objective(s); and de-implementation interventions, determinants of the use ofthe use of de-implementation interventions, and their effectiveness. We assessed included studies’ quality using the NIH Quality Assessment Tools. Results Out of 2,793 studies, 13 met our inclusion criteria. Included studies have been published between 2003 and 2020, and the majority (n = 9) of them were conducted in the USA. They covered several cancer types including prostate cancer (n = 4), multiple cancers (n = 3), hematologic cancers (n = 3), lung cancer (n = 1), breast cancer (n = 1), and gastrointestinal cancer (n = 1). Four studies were focused on de-implementing low-value diagnostic tests, six studies focused on de-implementing low-value treatment procedures, and three studies focused on low-value screening services. Most of the de-implementation interventions (n = 11) were effective in reducing low-value care. No study assessed the determinants of the use of de-implementation interventions. Conclusions This review showed that to accelerate the reduction of low-value cancer care, instead of solely relying on diffusion new evidence and guidelines (i.e., passive de-implementation), healthcare organizations should initiate de-implementation interventions and implement strategies purposefully aimed at reducing low-value care (i.e., active de-implementation). Additionally, future research should include a broader range of variables such as patients’ perspectives and preferences, unintended effects of de-implementing low-value care, and system-level factors when studying de-implementation.


2013 ◽  
Vol 11 (1) ◽  
pp. 59-62 ◽  
Author(s):  
Alan L. Kaplan ◽  
Mark S. Litwin ◽  
Karim Chamie

Sign in / Sign up

Export Citation Format

Share Document